DocWire News Editors

DocwireNews

During a presentation titled &ldquo;Severe Cutaneous Adverse Reactions (SCAR): Life-Threatening Drug Eruptions in the Pediatric Population,&rdquo; Robert Sidbury, MD, MPH, of Seattle Children&rsquo;s Hospital and the University of Washington, highlighted several life-threatening medication reactions, and he also reviewed less serious &ldquo;mimics&rdquo; such as urticaria multiforme, serum sickness like reaction, and erythema multiforme.When treating severe, possibly life-threatening cutaneous reactions in children, &ldquo;the stakes are high, and it is a fraught evaluation,&rdquo; Sidbury said, since the same symptoms can appear with a minor or major condition.Fever and rash can either be harmless or life-threatening, he said, with causes ranging from bug bites and drug rash to graft-versus-host disease to tick-borne illness or even Kawasaki disease.Sidbury recommended an &ldquo;ABC approach&rdquo; during diagnosis:<ul>
<li>A: Appearance (Does the child look sick?)</li>
<li>B: B cells/T cells (Consider immunosuppression.)</li>
<li>C: Contacts (for example, tick contact)</li>
<li>D: Drugs (Has there been exposure to any high-risk medications?)</li>
<li>E: Ecchymosis or petechia</li>
<li>F: fever for five days</li>
</ul>Sidbury and colleagues map the following factors when making a diagnosis: medications (high risk versus low risk); timing of fever, rash, itching, and eosinophilia versus atypical lymphocytosis; and morphology, including involvement of mucous membranes.&ldquo;There&rsquo;s no such thing as low risk,&rdquo; he said. &ldquo;Any drug can cause any morphology.&rdquo;Using case studies, Sidbury also reviewed several important skin reactions. Serum sickness like reaction often is caused by antibiotics and can result from vaccinations, so clinicians should be aware of recent immunizations. The reaction usually involves fever, rash, arthritis, and edema, as well as possible urticarial eruptions with bruising and facial edema. Onset is one to three weeks after medication exposure, and the reaction resolves in two to four weeks.Giant urticaria (also known as urticaria multiforme) is another common reaction, generally occurring after an infection in patients aged 1 to 5 years. Although children are not very sick, the rash is often dramatic, which is usually the reason they are brought to emergency department. Of note, urticaria does not blister. It can be challenging to distinguish this from a serum sickness-like reaction, although it is more important to distinguish both from other conditions (e.g., erythema multiforme).Sidbury also reviewed mycoplasma-induced rash and mucositis, which has very little skin involvement and generally has an infectious trigger that should be the target of treatment. Kawasaki disease, he said, often presents with non-exudative conjunctivitis and a polymorphic rash that is not blistering, unlike Stevens-Johnson syndrome. Drug rash with eosinophilia and systemic symptoms (DRESS) may occur three to four weeks after drug exposure, according to Sidbury. However, he stressed that 40% of children with DRESS do not have eosinophilia. Autoimmune thyroid dysfunction, which can occur four to 12 weeks after discharge, is an important consideration for allergists treating patients with DRESS.For practitioners, Sidbury offered some tips: Always consider whether the rash started on the outside of the body and worked its way in, or vice versa. Children and caregivers should receive general counsel that if they take any new medication by mouth and unfamiliar symptoms develop, they should STOP the medication and call the prescribing doctor.&nbsp;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Life-Threatening Drug Eruptions in Pediatrics

ACAAI 2018

During a presentation titled “Severe Cutaneous Adverse Reactions (SCAR): Life-Threatening Drug Eruptions in the Pediatric Population,” Robert Sidbury, MD, MPH, of Seattle ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe